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Introduction
Human milk has been suggested as a signifi-
cant potential source of infant lead exposure 
due to the redistribution of cumulative mater-
nal lead stores associated with bone resorp-
tion of pregnancy and lactation (Anderson 
and Wolff 2000; Silbergeld 1991). Maternal 
bone lead burden and breastfeeding practices 
are important predictors of maternal blood 
lead levels over the course of lactation (Tellez-
Rojo et al. 2002); however, plasma lead is the 
main biologically active compartment from 
which lead is available to cross cell membranes 
(Cavalleri et al. 1978; O’Flaherty 1993). The 
milk-to-plasma (M/P) ratio, used to express 
the relative efficiency of passive transfer of a 
chemical from the blood into milk (Larsen 
et al. 2003), has been reported to be < 1.0 for 
lead (Lawrence and Lawrence 1998, 2005; 
Wolff 1983), although human data available 
to confirm this relationship are limited.
There are some data from rodents on 
the lactational transfer and uptake of lead in 
the neonate. Kostial and Momcilovic (1974) 
showed that the peak transfer of radiolabeled 
lead in mice from mother to litter occurred 
during lactation. Keller and Doherty (1980) 
found that 25% of maternal bone lead burden 
in mice was transferred to offspring and that 
most of this activity occurred during lactation. 
Murine milk was found to concentrate lead at 
around 25 times the level   circulating in plasma.
Because maternal blood is the matrix 
from which lead is transferred to breast milk 
and, ultimately, to the breastfeeding infant, 
the relationship of lead in maternal blood 
and in breast milk is of key importance. Early 
studies supported the belief that human milk 
levels were one-tenth to one-fifth the   levels 
of lead in maternal blood (Abadin et al. 
1997). However, Gulson et al. (1998a) and 
Amarasiriwardena et al. (2013) have discussed 
in detail the analytical difficulties of quantify-
ing lead in breast milk. More recent studies 
of breast milk lead have consistently found 
maternal milk-to-blood lead ratios of ≤ 3% 
(Counter et al. 2004; Ettinger et al. 2004b; 
Gulson et al. 1998a; Li et al. 2000). Yet evi-
dence suggests that the plasma-to-blood lead 
ratio can vary quite widely among and within 
individuals (Smith et al. 2002), and this may 
be attributable to underlying differences in 
toxicokinetics—for example, with respect to 
δ-aminolevulinic acid dehydratase (ALAD) 
gene polymorphisms (Montenegro et al. 
2006, 2008). Although blood lead levels are 
highly correlated with plasma lead levels, 
lead in bone (particularly trabecular bone) 
exerts an additional independent influence 
on plasma lead (Hernandez-Avila et al. 1998; 
Schutz et al. 1996; Smith et al. 1996), and 
mobilization of lead from bone is ampli-
fied during lactation (Gulson et al. 1998b). 
Thus, the bioavailability of lead for transfer 
into breast milk may not be well reflected 
by maternal blood lead levels alone. Better 
understanding of lead kinetics in the lactating 
woman and breastfeeding infant are needed 
for risk assessment and policy development 
[Centers for Disease Control and Prevention 
(CDC) 2010; Kosnett et al. 2007; Landrigan 
et al. 2002] because it is now understood that 
even low levels of lead are harmful to human 
health and development (CDC 2012).
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Background: Human milk is a potential source of lead exposure. Yet lactational transfer of 
lead from maternal blood into breast milk and its contribution to infant lead burden remains 
poorly understood.
oBjectives: We explored the dose–response relationships between maternal blood, plasma, and 
breast milk to better understand lactational transfer of lead from blood and plasma into milk and, 
ultimately, to the breastfeeding infant.
Methods: We measured lead in 81 maternal blood, plasma, and breast milk samples at 1 month 
postpartum and in 60 infant blood samples at 3 months of age. Milk-to-plasma (M/P) lead ratios 
were calculated. Multivariate linear, piecewise, and generalized additive models were used to exam-
ine dose–response relationships between blood, plasma, and milk lead levels.
results: Maternal lead levels (mean ± SD) were as follows: blood: 7.7 ± 4.0 μg/dL; plasma: 
0.1 ± 0.1 μg/L; milk: 0.8 ± 0.7 μg/L. The average M/P lead ratio was 7.7 (range, 0.6–39.8) with 97% 
of the ratios being > 1. The dose–response relationship between plasma lead and M/P ratio was non-
linear (empirical distribution function = 6.5, p = 0.0006) with the M/P ratio decreasing by 16.6 and 
0.6 per 0.1 μg/L of plasma lead, respectively, below and above 0.1 μg/L plasma lead. Infant blood 
lead level (3.4 ± 2.2 μg/dL) increased by 1.8 μg/dL per 1 μg/L milk lead (p < 0.0001, R2 = 0.3).
conclusions: The M/P ratio for lead in humans is substantially higher than previously reported, 
and transfer of lead from plasma to milk may be higher at lower levels of plasma lead. Breast milk is 
an important determinant of lead burden among breastfeeding infants.
citation: Ettinger AS, Roy A, Amarasiriwardena CJ, Smith DR, Lupoli N, Mercado-García A, 
Lamadrid-Figueroa H, Tellez-Rojo MM, Hu H, Hernández-Avila M. 2014. Maternal blood, 
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To better understand the distribution and 
transfer of lead during lactation, we measured 
maternal plasma, blood, and breast milk lead 
concentrations at 1 month postpartum in a 
study of lactating women in Mexico City, 
Mexico. We also explored the relationship 
between breast milk lead and infant blood 
lead levels among their breastfeeding infants.
Materials and Methods
Study subjects. Subjects were participants in 
a longitudinal study of lead biomarkers and 
reproduction which has been described in 
detail elsewhere (Lamadrid-Figueroa et al. 
2006; Tellez-Rojo et al. 2004). Women 
were recruited during prenatal visits between 
May 1997 and July 1999 at one of three 
clinics of the Mexican Institute of Social 
Security (IMSS) in Mexico City and fol-
lowed throughout their pregnancy and for 
up to 1 year postpartum. All mothers were 
informed about the study procedures, and 
those who agreed to participate read and 
signed a letter of informed consent. The 
research protocol was approved by the eth-
ics committees of the National Institute of 
Public Health of Mexico and the participat-
ing hospitals, the Harvard School of Public 
Health, the Brigham and Women’s Hospital, 
and the University of California, Santa 
Cruz. A total of 463 pregnant women were 
recruited. Blood and plasma samples were 
collected at each trimester and at 1, 4, 7, and 
12 months postpartum. Lactating women 
were also asked to provide breast milk samples 
at the 1-month postpartum visit. This analy-
sis is limited to 81 subjects for whom there 
were lead values in breast milk, blood, and 
plasma at 1 month postpartum. Additionally, 
among a subset of 60 mother–infant pairs 
with infant blood lead levels at 3 months of 
age, we explored the effect of breast milk lead 
on infant lead burden in this population.
Plasma lead measurement. Before veni-
puncture, each subject’s arm was washed 
with ultrapure water and disinfected with 
reagent-grade alcohol. Thirteen milliliters of 
venous blood was then collected into a poly-
ethylene tube containing 100 USP sodium 
heparin (H-3393; Sigma Chemical Company, 
St. Louis, MO, USA) using gravity-assisted 
procedures to limit potential hemolysis. 
Samples were processed and shipped frozen 
to the trace metal facility at the University 
of California, Santa Cruz, for measurement 
of plasma lead using ultra-clean methods 
detailed elsewhere (Hernandez-Avila et al. 
1998; Smith et al. 1998). All samples were 
analyzed using inductively coupled plasma 
mass spectrometry (ICP-MS; Thermo 
Finnigan, Bremen, Germany). Potential 
contamination by lead from hemolyzed red 
cells was assessed by measuring levels of total 
plasma iron and free hemoglobin as described 
by Smith et al. (1998). This method yields 
a measurement precision of ≤ 0.5% RSD 
(relative standard deviation) for lead concen-
trations of > 0.05 ng/mL and an analytical 
detection limit of 0.01 ng/mL (0.01 μg/L). 
Blood lead measurement. Maternal and 
infant venous whole blood was collected into 
metal-free tubes (Vacutainer, B-D 367734; 
Becton-Dickinson, Franklin Lakes, NJ, 
USA) for blood lead analysis. Graphite fur-
nace atomic absorption spectrophotometry 
(model 3000; PerkinElmer, Norwalk, CT, 
USA) was used to quantify blood lead accord-
ing to a technique described by Miller et al. 
(1987). Measurements were performed at 
the ABC Hospital Trace Metal Laboratory, 
which participated in the CDC blood lead 
proficiency testing program administered by 
the Wisconsin State Laboratory of Hygiene 
(Madison, WI). The laboratory standardiza-
tion program provided external quality con-
trol specimens varying from 2 to 88 μg/dL, 
and our laboratory maintained acceptable 
performance during the study period. 
The limit of detection for this method is 
0.1 μg/dL (1 μg/L).
Breast milk lead measurement. Breast 
milk samples were collected from lactating 
women using specific techniques designed 
to minimize potential for environmental 
contamination and any potential variabil-
ity in breast milk lead over time (related to 
time of day, milking session time, months 
postpartum). Before manual expression of 
milk, the breast was washed with deionized 
water that also was collected and analyzed for 
lead contamination. Ten milliliters of milk 
was collected in preleached polypropylene 
containers. Samples were shipped frozen 
and stored at –30°C (Fisher IsoTempPlus, 
New York, NY, USA) until analysis. Breast 
milk sample preparation was performed 
at University of Massachusetts Research 
Institute for Analytical Chemistry (Amherst, 
MA), and instrumental analysis was per-
formed at the Trace Metals Laboratory of 
Harvard School of Public Health. Digestion 
was performed using nitric acid in high tem-
perature high pressure asher (HPA) (Anton 
Paar USA, Ashland, VA, USA), and lead con-
tent in the samples was analyzed by isotope 
dilution–inductively coupled plasma mass 
spectrometry (ID-ICPMS) (Sciex Elan 6100-
DRC; Perkin Elmer, Norwalk, CT, USA) 
by methods previously described in detail 
(Amarasiriwardena et al. 2013; Ettinger et al. 
2004b). The precision for these measurements 
ranged from 0.3 to 7.8% RSD, and the ana-
lytic detection limit by this method is 0.01 
ng/mL (0.01 μg/L).
Statistical analysis. Univariate distributions 
were examined for all variables. Outliers were 
identified as values > 3 SDs from the mean: 
Subjects with blood lead levels > 30 μg/dL 
(n = 1) and plasma lead levels > 1 μg/L (n = 2) 
were excluded. Milk and plasma lead concen-
trations are expressed in parts per billion (ppb), 
whereas blood lead concentrations, typically 
expressed in micrograms per deciliter, were con-
verted to micrograms per liter as necessary to 
calculate transfer indices (plasma–blood lead 
ratio, breast milk–blood lead ratio). The M/P 
ratio was calculated by dividing breast milk lead 
concentration (micrograms per liter) by plasma 
lead concentration (micrograms per liter).
Bivariate analyses were carried out to 
explore the relationships between the differ-
ent biomarkers of lead exposure. Spearman 
tests of correlation were used and correla-
tion coefficients (ρ) with p-values reported. 
Nonparametric smoothing [locally weighted 
scatterplot smoothing (LOWESS), band-
width 0.75] was used to explore the shape 
of the   associations between the different 
lead biomarkers.
Multivariable linear regression models 
were fitted using ordinary least-squares meth-
ods to estimate associations between the blood 
or plasma and breast milk lead levels. Given 
the limited sample size available for analysis, 
extensive covariate adjustment was not feasi-
ble. We chose to investigate covariates (mater-
nal age, dietary calcium intake, and systolic 
blood pressure) based on a priori knowledge 
of biological significance and review of the 
scientific literature. Covariates were retained 
in the models if the main effect estimate of 
plasma or blood lead on breast milk lead 
changed by > 10% or if it increased the model 
coefficient of determination (R2) by > 10%. 
To explore potential nonlinear associations, 
we also examined the relationships between 
the variables using nonparametric regression 
with generalized additive models (GAMs). 
The GAM models allowed us to examine pos-
sible nonlinear effects using a smooth func-
tional term corresponding to plasma lead in 
the multivariate model. The smoothing term 
was fitted by using penalized regression splines 
with degree of smoothness selected by cross-
validation technique, allowing us to determine 
the functional relationship between the differ-
ent matrices in a flexible, data-adaptive way 
instead of being restricted to a linear relation-
ship. Where the GAMs indicated a non  linear 
relationship, we explored the effects using 
piecewise linear models to describe the trend.
We explored the contribution of breast 
milk lead to infant blood lead levels among 
a subset of mother–infant pairs using multi-
variate regression accounting for breastfeeding 
duration (months of exclusive breastfeeding) 
over the preceding 3 months of the infant’s 
life. Stratified and interaction models were 
also fitted to determine whether breastfeed-
ing status (yes/no, exclusively breastfed in the 
preceding month) altered this relationship. 
Sensitivity analyses of the breast milk–infant Transfer of lead to human milk
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blood lead association were carried out to 
assess the additional contribution of lead from 
umbilical cord blood (where available) among 
36 mother–infant pairs, accounting for infant 
birth weight (as a proxy for the amount of 
milk consumed) and breastfeeding status. 
All statistical analyses were performed using 
SAS® for Windows, version 9.3 (SAS Institute 
Inc., Cary, NC, USA) and R Programming 
Language (version 2.12.2; R Development 
Core Team, Vienna, Austria).
Results
Maternal lead levels at 1 month postpartum 
were as follows: blood: 7.7 ± 4.0 (range, 
1.7–28.7) μg/dL; plasma: 0.1 ± 0.1 (range, 
0.03–0.5) μg/L; and breast milk: 0.8 ± 0.7 
(range, 0.04–3.2) μg/L. The plasma-to-blood 
ratio ranged from 0.06 to 0.42, and the aver-
age M/P lead ratio was 7.7 (range, 0.6–39.8) 
with 97% of the ratios being > 1. Infant blood 
lead at 3 months of age was 3.4 ± 2.2 (range, 
0.5–14.5) μg/dL (Table 1). Significant correla-
tion between the different lead biomarkers was 
observed (Table 2).
The multivariate linear relationships, 
adjusted for maternal age, dietary calcium 
intake and systolic blood pressure, between 
maternal blood lead, plasma lead, and breast 
milk lead are reported in Table 3. Figure 1A 
suggests a curvilinear association between 
blood and plasma lead after excluding outliers; 
however, the association best fit a log-linear 
model. A 1-μg/dL increase in blood lead was 
associated with an increase of 0.11 (95% CI: 
0.09, 0.13) natural log (ln) (micrograms per 
liter) plasma lead and explained 57% of the 
variation in plasma lead (p < 0.0001); how-
ever, the multivariate adjusted GAM model 
indicated that the association was linear 
[empirical distribution function (EDF) = 1] 
(data not shown). As Figures 1B and 2A 
indicate, blood and plasma lead levels have 
nonlinear associations with breast milk lead. 
Therefore, to describe the association between 
plasma and breast milk lead, we addition-
ally fit a piecewise linear model with a knot 
value of 0.1 μg/L. The change in breast milk 
lead per 0.1-μg/L increase of plasma lead was 
–2.0 (95% CI: –7.4, 3.5) μg/L when plasma 
lead levels were < 0.1 μg/L, and 1.6 (95% 
CI: 0.1, 3.2) μg/L when plasma lead levels 
were > 0.1 μg/L. The difference in slope was 
marginally significant in the piecewise linear 
model (p = 0.05). Figure 2B shows that the 
plasma lead to M/P ratio relationship (indica-
tive of relative transfer of lead) varied over the 
observed range of plasma lead levels.
The adjusted plasma–breast milk lead 
relationship was observed to be nonlinear 
with considerable variability over the range 
of plasma lead levels (Figure 3A; EDF = 4.2). 
The M/P ratio was also nonlinear (EDF = 6.5) 
and changed over the plasma lead range 
(Figure 3B). Below and above 0.1 μg/L the 
M/P ratio decreased, respectively, by 16.6 
(95% CI: –24.6, –8.7) and 0.6 (95% CI: 
–2.5, 1.2) per 0.1 μg/L plasma lead. The dif-
ference in slope was statistically significant in 
the piecewise linear model (p = 0.002).
Infant blood lead was significantly 
associated with maternal breast milk levels 
(Table 4). Breast milk lead explained 30% 
of the variation in infant blood lead levels. 
After accounting for number of months of 
breastfeeding, infant blood lead at 3 months 
of age increased by 1.8 (95% CI: 1.1, 
2.6) μg/dL per μg/L breast milk lead. Further, 
infant blood lead increased by 2.2 (95% CI: 
1.1, 3.3) μg/dL among infants exclusively 
breastfed in the preceding month, compared 
with 1.1 (95% CI: 0.01, 2.2) μg/dL among 
those not breastfed in the preceding month 
(p-value for interaction = 0.06), indicating 
Table 1. Summary of mother–infant lead levels in different matrices and transfer indices, Mexico City, 
1997–1999.
Lead matrix or transfer index n Mean ± SD Minimum Maximum
Maternal (1 month postpartum)
Blood lead (μg/dL) 81 7.7 ± 4.0 1.7 28.7
Plasma lead (μg/L) 81 0.1 ± 0.1 0.03 0.5
Breast milk lead (μg/L) 81 0.8 ± 0.7 0.04 3.2
Plasma–blood lead ratio 81 0.2 ± 0.1 0.06 0.42
Breast milk–blood lead ratio 81 1.2 ± 0.9 0.1 4.2
Breast milk–plasma lead ratio 81 7.7 ± 7.1 0.6 39.8
Infant (3 months of age)
Blood lead (μg/dL 60 3.4 ± 2.2 0.5 14.5
Table 2. Correlation matrixa for mother–infant lead biomarkers, Mexico City, 1997–1999.
Biomarker of lead exposure Breast milkb Bloodb Plasmab Bloodc
Maternal
Breast milk 1.00 0.44* 0.31** 0.34**
Blood 1.00 0.76* 0.65*
Plasma 1.00 0.44**
Infant blood 1.00
aSpearman correlation coefficients (ρ); prob > |r| under H0: ρ = 0. bMaternal: sample collected 1 month postpartum, 
n = 81. cInfant blood: sample collected at 3 months of age, n = 60. *p < 0.0001. **p < 0.01.
Table 3. Multivariatea linear associations between lead levels in maternal plasma and maternal blood, 
and between lead levels in breast milk and lead in maternal blood or plasma.
Outcome Exposure β (95% CI) SE R2 p-Valueb
Plasmac Blood 0.1 (0.09, 0.1) 0.01 0.6 < 0.0001
Breast milkd Blood 0.1 (0.04, 0.1) 0.02 0.2 < 0.0001
Breast milke Plasma 2.3 (1.0, 3.6) 0.7 0.2 0.001
Breast milkf Plasma: ≤ 0.1 μg/L –2.0 (–7.4, 3.5) 2.7 0.2 0.05
Plasma: > 0.1 μg/L 1.6 (–0.1, 3.2) 0.9
aAll models adjusted for maternal age, dietary calcium intake, and systolic blood pressure. bR2 p-value for models 
of maternal blood or plasma as continuous variables, or p-value for the difference in coefficients (slopes) > 0.1 and 
≤ 0.1 μg/dL maternal plasma lead. cLinear regression of maternal plasma lead [ln(μg/L)] and maternal blood lead (μg/dL). 
  dLinear regression of breast milk lead (μg/L) and maternal blood lead (μg/dL). eLinear regression of breast milk lead 
(μg/L) and maternal plasma lead (μg/dL). fLinear regression of breast milk lead (μg/L) and maternal plasma lead as a 
piecewise linear variable with knot value at 0.1 μg/L.
Figure 1. Unadjusted associations between maternal blood lead and maternal plasma (A) and breast milk 
lead (B) levels. The solid line represents a smoothed curve through the set of individual data points (open 
circles) from a robust locally weighted regression (bandwidth = 0.7).
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effect modification by breastfeeding status 
(Figure 4).
Sensitivity analyses indicate that this rela-
tionship remained even after accounting for 
umbilical cord blood lead and birth weight; the 
increase in infant blood lead per unit change 
in breast milk lead was higher by 2.3 μg/dL 
among children exclusively breastfed compared 
with those not exclusively breastfed in the pre-
vious month (p-value for interaction = 0.06) 
(data not shown). Among infants exclusively 
breastfed, breast milk and umbilical cord blood 
explained 37% and 33% of variation in infant 
blood lead, respectively, compared with 10% 
and 50% of the variation among infants not 
exclusively breastfed in the preceding month.
Discussion
The results of this study suggest that the 
maternal toxicokinetics of lead between the 
compartments of blood, plasma (the bioavail-
able fraction), and breast milk (the exposure 
medium for breastfeeding infant) are complex. 
The relationship between maternal blood and 
plasma in our population had a curvi  linear 
association best described by a log-linear 
function, suggesting variability in partition-
ing of lead between the erythrocyte compo-
nent of blood and plasma over the range of 
lead exposure. This is very similar to that 
observed among 63 nonpregnant (Smith et al. 
2002) and 237 pregnant women in Mexico 
(Lamadrid-Figueroa et al. 2006). Plasma 
lead increases as a fraction of blood lead. The 
plasma–blood lead ratio in our population 
varied from about 0.1 to 0.4, and the dose–
response across the range of blood lead levels 
(data not shown) was also similar to the hockey 
stick–shaped association seen in the study by 
Smith et al. (2002). Therefore, the amount 
of lead available for transfer from plasma into 
breast milk varied over the range of blood lead, 
so blood lead may not be the best matrix in 
which to study the kinetics of lead transfer 
into breast milk and, ultimately, as a source of 
exposure to the breastfeeding infant.
Our results suggest that the transfer of lead 
from plasma to breast milk was also variable 
across the range of plasma lead. The M/P ratios 
reported here for lead are higher than previ-
ously estimated in humans as ≤ 1.0, and may 
actually be more similar to results reported 
by earlier animal studies where lead concen-
trated in breast milk. In fact, the M/P ratio for 
lead was found to be nonlinear, with the high-
est M/P ratios at the lowest levels of plasma 
lead, which dropped off steeply until around 
0.1 μg/L plasma lead and then tapered off. 
This could be explained by passive transfer of 
lead into breast milk driven by high affinity 
compartment in milk, thus allowing binding 
at low concentrations and drawing lead into 
milk. However, this high affinity compartment 
would have a low overall capacity, leading to 
rapid saturation at around 0.1 μg/L plasma 
Figure 2. Unadjusted associations between maternal plasma lead and (A) maternal breast milk lead and 
(B) breast M/P ratio. The solid line represents a smoothed curve through the set of individual data points 
(open circles) from a robust locally weighted regression (bandwidth = 0.7).
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Figure 3. Nonlinear dose–response relationship between plasma lead and breast milk lead (EDF = 4.2) (A) 
and M/P ratio (EDF = 6.5) (B), from GAMs using penalized splines and adjusted for maternal age, dietary 
calcium intake, and systolic blood pressure. The M/P ratio decreased by 16.6 (95% CI: –24.6, –8.7) and 
0.6 (95% CI: –2.5, 1.2) per 0.1-μg/L plasma lead below and above 0.1 μg/L plasma lead, respectively, in a piece-
wise linear multivariate model. Solid lines represents effect estimates and dashed lines represent 95% CIs.
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Table 4. Relationship between breast milk lead (μg/L, 1 month postpartum) and infant blood lead (μg/dL, 
3 months of age).
Predictor  Estimate (95% CI) p-Value Partial R2
Unadjusted (n = 60)
Breast milk 1.8 (1.1, 2.6) < 0.0001 0.3
Adjusted (n = 60)
Breast milk 1.8 (1.1, 2.6) < 0.0001 0.3
Breastfeeding (months) 0.3 (–0.6, 0.8) 0.8 0.0
Stratified modela
Breastfed in preceding month (n = 29)
Breast milk 2.2 (1.1, 3.3) 0.0001 0.4
Not breastfed in preceding month (n = 31)
Breast milk 1.1 (0.01, 2.2) 0.04 0.1
ap = 0.06 for interaction between breast milk lead and breastfeeding status.
Figure 4. Unadjusted association between breast 
milk lead and infant blood lead stratified by breast-
feeding status for infants exclusively (yes) and not 
exclusively breastfeeding (no) in preceding month. 
Lines represent smoothed curve through the set 
of individual data points from a robust locally 
weighted regression (bandwidth = 0.7).
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lead and the consequent leveling off of the 
M/P ratio as passive transfer resumes (driven 
only by the increase in plasma lead levels).
A possible candidate for this high-affinity, 
low-capacity compartment in milk could 
be the protein casein, which is involved in 
calcium transport into milk. Several stud-
ies indicate that milk casein binds lead with 
high affinity in rats, mice, cows, and humans 
[reviewed by Anastacio Ada et al. (2004)]. 
However, the milk casein concentration and 
amount of binding to casein in milk is much 
higher in animals than in humans (Hallen 
and Oskarsson 1995; Lönnerdal 2013; Rosen 
et al. 2009), which would explain the ease 
with which binding becomes saturated in 
human milk (Oskarsson et al. 1995).
Current recommendations for cessation 
of breastfeeding at maternal blood lead levels 
> 40 μg/dL are based on an M/P ratio assumed 
to be < 1 for lead (CDC 2010; Kosnett et al. 
2007; Lawrence and Lawrence 1998, 2005). 
We found that, in most cases (97%), the M/P 
lead ratio was > 1, indicating that the milk 
lead concentration is higher than the mater-
nal plasma concentration. Although the M/P 
ratios up to 40 observed in our study might 
seem to be disturbingly high, in fact they occur 
only at such low plasma lead concentrations 
that the associated milk lead concentration is 
still relatively low. For example, the extreme 
of the observed M/P ratios in our study, 39.8, 
corresponds to a milk lead concentration of 
1.7 μg/L at a plasma lead concentration of 
0.04 μg/L. Even at a higher and more com-
monly observed plasma lead concentration of 
0.1 μg/L, an M/P ratio of 40 would corre-
spond to a milk lead concentration of 4 μg/L.
At high blood lead concentrations 
(> 40 μg/dL), the relationship between the 
concentration of lead in serum and its concen-
tration in blood becomes nonlinear (Manton 
and Cook 1984; Manton et al. 2001). The 
blood lead concentration at which deviation 
from linearity in the plasma-blood lead rela-
tionship is clearly apparent is both   population- 
and model-dependent but, in general, it 
appears that blood lead concentrations 
> 40 μg/dL are associated with significant 
nonlinearity in humans (Hernandez-Avila 
et al. 1998; O’Flaherty 1993; Schutz et al. 
1996). Thus, it can be posited that when 
maternal blood lead concentrations exceed 
about 40 μg/dL, the milk-to-blood lead ratio 
may be greater than it is at lower maternal 
blood lead concentrations.
The proposed nonlinearity in the milk-to-
blood lead relationship has been observed in 
lactating mice and rats with blood lead con-
centrations > 3 μg/dL (Hallén et al. 1996) as 
well as in cows at blood lead concentrations 
exceeding 20–30 μg/dL (Oskarsson et al. 
1992). Hallén and Oskarsson (1993) observed 
a linear relationship between milk lead and 
maternal plasma lead in rats and mice through-
out the entire concentration range of their 
studies. Oskarsson et al. (1995) have also noted 
a rapid rise in milk lead above blood lead levels 
> 40 μg/dL in human samples from a Mexico 
City study (Namihira et al. 1993), in which 
the mean blood lead was 46 μg/dL, suggesting 
a curvilinear relationship between blood lead 
and milk lead. The variance explained in the 
linear models of breast milk lead are approxi-
mately the same for blood and plasma lead 
in our study; however, we found the blood–
breast milk lead association to be linear while 
the plasma–breast milk lead was significantly 
nonlinear. Therefore, we fit piecewise linear 
models, with a knot at the point of inflection 
of 0.1 μg/L, to describe the plasma–breast 
milk lead relationship, which may not fully 
be capturing the variability of the nonlinear 
  relationship as shown in Figures 2A and 3A.
The potential magnitude and range 
of increases in the milk-to-blood lead 
ratio at maternal blood lead concentrations 
> 40 μg/dL are not well quantified in humans 
and are outside the range of blood lead levels 
in our current study. However, although the 
milk-to-blood lead ratio may increase as mater-
nal blood lead concentrations exceed 40 μg/dL, 
the milk-to-plasma lead ratio should not 
change significantly at higher maternal blood 
lead concentrations. Nonetheless, the possibil-
ity that milk lead increases disproportionately 
to blood lead in women with high blood lead 
levels should be considered when discussing 
breastfeeding with women whose blood lead 
levels exceed 40 μg/dL.
Our findings here do not suggest that 
measurement of maternal plasma or breast 
milk lead are likely to become clinically use-
ful environmental health measures because 
these methods require technically challenging 
ultra-clean specimen collection and analysis 
protocols. However, when properly collected 
and analyzed, these biological markers of expo-
sure are useful tools in research efforts to bet-
ter understand lead kinetics in the lactating 
woman and breastfeeding infant. We used dif-
ferent laboratories and analytic procedures for 
quantification of lead in the various biological 
matrices to employ the best available meth-
ods for the key matrices of interest (plasma 
and breast milk). Blood lead is a surrogate, 
measured with error, for the toxicologically 
available lead fraction, and larger effect size 
estimates observed in studies using plasma lead 
suggest many previous studies using blood lead 
may have had effect estimates downwardly 
biased by measurement error.
Given the unique nutritional character-
istics of human milk, breastfeeding is under-
stood to be the optimal mode of nutrient 
delivery to full-term infants. The benefits 
of breastfeeding are so compelling that very 
few situations definitively contraindicate 
breastfeeding (American Academy of Pediatrics 
2012). However, wide ranges of breast milk 
lead levels have been documented in popula-
tion studies of women (Abadin et al. 1997; 
Koyashiki et al. 2010), and the human 
data available to estimate the risk this poses 
to the breastfeeding infant are limited 
(Mushak 1999).
Our results suggest that breast milk 
lead is a significant and important source of 
infant lead exposure accounting for approxi-
mately 30% of variation in infant blood lead 
levels. This was higher among infants who were 
exclusively breastfed (37%) than among those 
not exclusively breastfed (10%), suggesting 
that breast milk is an important contributor 
to infant lead burden on top of any concur-
rent environmental and in utero exposures. 
Although a limitation of the present study is 
that we did not have concurrent infant blood 
lead levels available at 1 month postpartum, we 
made the assumption that the ranking of lead 
levels within the population remained stable 
over the first 3 months of infant life, and we 
also accounted for breastfeeding practices in 
our models.
Previously we have reported that even 
among a population of women with relatively 
high cumulative lifetime exposures to lead, 
levels of lead in breast milk were low, influ-
enced both by current lead exposure and by 
redistribution of bone lead accumulated from 
past environmental exposures (Ettinger et al. 
2004b). Although these breast milk lead levels 
were relatively low, they clearly had a strong 
influence on infant blood lead over and above 
the influence of maternal blood lead. Breast 
milk lead accounted for 12% of the variance, 
and was significantly correlated (r = 0.32, 
p < 0.0001) with infant blood lead levels at 
1 month of age (Ettinger et al. 2004a). In 
that study, we estimated that a difference of 
approximately 2 μg/L in breast milk lead was 
associated with a 0.82-μg/dL increase in blood 
lead for breastfeeding infants at 1 month of 
age (Ettinger et al. 2004a). In the current 
study, a 1-μg/L increase in breast milk lead 
increased infant blood lead by 1.8 μg/dL at 
3 months of age (p-value < 0.0001). This was 
higher among infants exclusively breastfed in 
the previous month (2.2 μg/dL) compared 
with breastfeeding infants who were not 
exclusively breastfed in the preceding month 
(1.1 μg/dL) (p-value for interaction = 0.06).
In another study of breast milk and infant 
blood lead levels, milk lead accounted for 10% 
of the variance in 6-month blood lead, and 
there was a linear dose–response relationship 
between breast milk and infant blood lead 
at 6 months of age (r = 0.42, p = 0.0003) 
(Rabinowitz et al. 1985). Despite the fact that 
human milk composition varies among indi-
viduals (Ballard and Morrow 2013), the high 
percentage of lead in the milk whey fraction Ettinger et al.
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suggests that most lead in human milk is bio-
available to the breastfeeding infant (Anastacio 
Ada et al. 2004). To the extent that lead can be 
found in infant formula, the relative bioavail-
ability of such lead may be less than that of 
lead in breast milk. For example, it has been 
well documented that iron is more readily 
absorbed from breast milk than from infant 
formula (Lönnerdal 1985). Rabinowitz et al. 
(1985) found breast milk to be the stron-
gest correlate of 6-month blood lead levels, 
whereas formula lead correlated poorly with 
infant blood lead levels. However, Gulson 
et al. (1998a) showed that the contribution of 
formula to infant blood lead varied from 24% 
to 68% in exclusively formula-fed infants. 
Further, a study of breastfeeding duration and 
infant blood lead reported that longer breast-
feeding was associated with higher infant lead 
concentrations in three countries, in three dif-
ferent decades, in settings with differing breast-
feeding patterns, environmental lead sources, 
and infant lead levels (Lozoff et al. 2009). 
Nonetheless, lead in water used to reconstitute 
powdered infant formula (Baum and Shannon 
1997) and other dietary intakes are also poten-
tial sources of lead exposure to infants beyond 
the contribution from lead in breast milk.
Conclusions
In this study we measured lead in several 
maternal and infant biomarkers simultane-
ously, including blood, plasma, and breast 
milk, using state-of-the-art, ultra-clean meth-
ods for specimen collection and laboratory 
analysis. We found that the M/P ratio for 
lead in humans is substantially higher than 
previously reported as being ≤ 1.0, and the 
transfer of lead from plasma to breast milk 
may be higher at lower levels of plasma lead. 
Breast milk represents an additional impor-
tant source of lead exposure to breastfeeding 
infants over and above the contribution from 
in utero exposure. This has implications for 
policy decisions regarding counseling the lead-
exposed woman on breastfeeding, because cur-
rent recommendations appear to be based on 
limited empirical evidence.
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